Evidence map›Paper›PMID 35457773›Full record

SynthesisInternational journal of environmental research and public health2022

Opioid Prescription Method for Breathlessness Due to Non-Cancer Chronic Respiratory Diseases: A Systematic Review.

Yasuhiro Yamaguchi, K M Saif-Ur-Rahman, Motoko Nomura, Hiromitsu Ohta, Yoshihisa Hirakawa, Takashi Yamanaka, Satoshi Hirahara, Hisayuki Miura

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Guideline
  2. Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Yasuhiro YamaguchiDepartment of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.ORCID 0000-0002-6899-4406
K M Saif-Ur-RahmanDepartment of Public Health and Health Systems, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan.ORCID 0000-0001-8702-7094
Motoko NomuraDepartment of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
Hiromitsu OhtaDepartment of Pulmonary Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
Yoshihisa HirakawaDepartment of Public Health and Health Systems, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan.
Takashi YamanakaDepartment of Home Care Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.ORCID 0000-0002-6259-0195
Satoshi HiraharaTokyo Fureai Medical Co-op Research & Education Center, Tokyo 114-0004, Japan.
Hisayuki MiuraDepartment of Home Care and Regional Liaison Promotion, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.ORCID 0000-0002-4780-9857
Jichi Medical University · JPInternational Centre for Diarrhoeal Disease Research · BDNagoya University · JPNational Center for Geriatrics and Gerontology · JPThe University of Tokyo · JP

Funding

Japan Agency for Medical Research and Development 19dk0110038h0001, 20dk0110038h0002, and 21dk0110038s0303
6 · The paper itself

Abstract

A previous pooled analysis demonstrated significant relief of breathlessness following opioid administration in patients with chronic obstructive pulmonary disease. However, in clinical practice, it is important to know the characteristics of patients responding to opioids, the best prescription methods, and the evaluation measures that can sufficiently reflect these effects. Thus, we performed a systematic review of systemic opioids for non-cancer chronic respiratory diseases. Fifteen randomized controlled studies (RCTs), four non-randomized studies, two observational studies, and five retrospective studies were included. Recent RCTs suggested that regular oral opioid use would decrease the worst breathlessness in patients with a modified Medical Research Council score ≥ 3 by a degree of 1.0 or less on a scale of 1-10. Ergometer or treadmill tests indicated mostly consistent significant acute effects of morphine or codeine. In two non-randomized studies, about 60% of patients responded to opioids and showed definite improvement in symptoms and quality of life. Furthermore, titration of opioids in these studies suggested that a major proportion of these responders had benefits after administration of approximately 10 mg/day of morphine. However, more studies are needed to clarify the prescription method to reduce withdrawal due to adverse effects, which would lead to significant improvements in overall well-being.

Indexed as

Analgesics, OpioidPulmonary Disease, Chronic ObstructiveDyspneaHumansMorphinePrescriptionsAnalgesics, OpioidMorphinebreathlessnesschronic obstructive pulmonary diseasedyspneainterstitial lung diseasemorphineopioidpalliative care

Identifiers

PMID35457773
PMCPMC9024433
OpenAlexW4224218670

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.